Can Losartan Make You Gain Weight? Other Side Effects

Losartan does not typically cause weight gain. Clinical studies have found the drug to be “metabolically neutral,” meaning it does not meaningfully affect glucose metabolism, fat storage, or lipid levels in most people who take it.¹ If the number on your scale has gone up since starting losartan, the explanation is more likely fluid retention from an underlying condition or a coincidental lifestyle change than a direct drug effect. That said, losartan does carry a real side-effect profile worth understanding, some of it subtle and some of it serious.

Why Losartan Gets a Clean Bill on Weight

Some blood-pressure medications are well known for nudging the scale upward. Older beta-blockers can slow metabolism slightly. Certain calcium channel blockers promote ankle swelling that registers as extra pounds. Losartan, an angiotensin II receptor blocker (ARB), sidesteps most of those mechanisms. A head-to-head comparison with the beta-blocker metoprolol found that losartan had no significant adverse effect on insulin secretion, glucose tolerance, or blood lipids.¹ A separate study in patients with high cholesterol and high blood pressure actually found small but meaningful drops in total cholesterol, LDL cholesterol, and triglycerides after losartan treatment.²

There is one wrinkle worth knowing about at the molecular level, though it does not change the practical answer. One of the breakdown products of losartan in the body, called EXP3179, partially activates a receptor involved in fat-cell development. In lab experiments, this metabolite triggered fat-cell maturation at about half the potency of the diabetes drug pioglitazone, a medication that does cause weight gain.³ Researchers think this activity helps explain some of losartan’s beneficial metabolic effects rather than promoting actual fat accumulation. In human studies, the net result is metabolic neutrality or a slight improvement in blood lipids, not weight gain.

When the Scale Goes Up Anyway

If you started losartan and noticed a few extra pounds, the most likely culprits are not the drug itself but conditions losartan is commonly prescribed alongside. Heart failure, kidney disease, and poorly controlled blood pressure all promote fluid retention, and losartan is a front-line treatment for all three. A patient starting losartan for heart failure who also takes a higher salt load or whose kidney function is declining may see weight creep up from retained fluid. That fluid gain is a signal to talk to your doctor about the underlying condition, not necessarily about losartan.

It is also worth checking other medications on your list. If losartan was added while you stayed on a beta-blocker or a corticosteroid, one of those co-prescribed drugs could be the source. Losartan is sometimes combined with a calcium channel blocker like amlodipine, which can cause noticeable ankle and lower-leg swelling in some people. When losartan is added to amlodipine, the combination may actually reduce the degree of peripheral edema compared to amlodipine alone.⁴

The Side Effects That Actually Do Show Up

Losartan is generally well tolerated compared to many other blood-pressure drugs. In a randomized comparison with the ACE inhibitor lisinopril and the calcium channel blocker amlodipine, losartan produced the fewest side effects overall and the lowest dropout rate, while achieving similar blood-pressure control.⁵ But “better tolerated” does not mean side-effect free. The effects that do occur range from mild nuisances to a handful of genuinely dangerous reactions.

The most common complaints are dizziness, lightheadedness (especially when standing up quickly), and occasional headache. These tend to be most noticeable in the first few weeks after starting the drug or after a dose increase, and they usually fade as the body adjusts. Upper respiratory infections and back pain are also reported frequently in clinical trials, though they appear at similar rates in people taking a placebo, making it hard to know whether losartan is truly to blame.

Potassium Levels and Kidney Function

The side effect that gets the most clinical attention with losartan and every other drug in its class is elevated potassium. Losartan works by blocking angiotensin II, a hormone that, among other things, stimulates the release of aldosterone, which tells the kidneys to excrete potassium. Block the hormone, and the kidneys hold onto more potassium. In a large trial of patients with type 2 diabetes and kidney disease, roughly four in ten patients on losartan had potassium levels at or above the upper boundary of normal by six months, compared to about two in ten on placebo.⁶

The risk scales with dose. An analysis from the HEAAL trial in heart-failure patients found that high-dose losartan (150 mg) increased the risk of dangerously high potassium by about 21% compared to the standard 50 mg dose, while at the same time lowering the chance of potassium dropping too low.⁷ Mild elevations often cause no symptoms, but severely high potassium can trigger dangerous heart-rhythm disturbances. That is why blood work to check potassium and kidney function is standard after starting the drug, especially in anyone with diabetes, kidney problems, or heart failure.

Certain drug combinations amplify the potassium risk. Potassium-sparing diuretics (like spironolactone), potassium supplements, NSAIDs such as ibuprofen, and the antibiotic trimethoprim can all push levels higher when taken alongside losartan.⁸ If you take losartan and reach for an over-the-counter NSAID regularly for aches and pains, that combination is one your doctor should know about.

Losartan can also affect kidney function directly. In early-to-moderate kidney disease, particularly in people with type 2 diabetes, it has shown protective effects, reducing the risk of disease progression by roughly a quarter beyond what blood-pressure reduction alone would explain.⁹ That benefit flips in advanced kidney disease, where starting or increasing an ARB can paradoxically worsen kidney function. Clinicians are advised to recheck kidney labs within a couple of weeks of starting losartan in anyone with significantly reduced kidney function.¹⁰ Acute kidney problems in this setting are not common, but when they occur they tend to develop quickly after the first dose, making early monitoring important.¹¹

Angioedema, a Rare but Dangerous Reaction

Angioedema is the side effect that keeps pharmacists vigilant. It involves sudden, deep swelling under the skin, usually around the lips, tongue, throat, or eyes. When it involves the airway, it can become life-threatening. The condition is more famously linked to ACE inhibitors like lisinopril and enalapril, but it can occur with ARBs too, including losartan.¹² The risk is thought to be lower with ARBs than with ACE inhibitors, but among the ARBs, losartan appears to carry a somewhat higher angioedema risk than other members of the class.¹³

A practical question that often comes up is whether someone who had angioedema on an ACE inhibitor can safely switch to losartan. The cross-reactivity rate appears to be low, under 10% in the published literature, and clinical guidelines generally consider an ARB a reasonable option in that scenario given the cardiovascular and kidney benefits of staying on a drug that blocks the renin-angiotensin system.¹⁴ Still, the switch is usually done under close medical supervision, with a plan in place in case swelling recurs.

A Rare Gut Problem That Mimics Celiac Disease

There is a condition called sprue-like enteropathy that has been linked to ARBs, most commonly olmesartan but increasingly recognized with losartan. It involves damage to the lining of the small intestine that looks very much like celiac disease: villous atrophy (blunting of the tiny finger-like projections that absorb nutrients), chronic diarrhea, abdominal pain, and sometimes significant weight loss and nutritional deficiencies.¹⁵ The condition is rare, but it can be stubbornly misdiagnosed because the symptoms and biopsy findings overlap so heavily with celiac disease. When celiac blood tests come back negative and someone has been on losartan for months or years, the drug deserves consideration as the cause.

Case reports have described the condition developing after as little as a few months or as long as several years of losartan use, and it resolves after the drug is stopped. In at least one case, the enteropathy was accompanied by skin ulcers that also healed after discontinuation.¹⁶ The irony here is that this condition causes weight loss, not gain, but it is worth mentioning because unexplained digestive symptoms on losartan are something many patients would not think to connect to a blood-pressure pill.

Losartan Versus ACE Inhibitors on Tolerability

Many people end up on losartan because they did not tolerate an ACE inhibitor, and the most common reason for that switch is a dry, persistent cough. ACE inhibitors cause cough in a substantial fraction of users by allowing the buildup of a substance called bradykinin. In the head-to-head trial mentioned earlier, coughing affected almost a third of patients on lisinopril but only about 8% on losartan.⁵ Losartan blocks the same hormonal pathway at a different point, which largely avoids the bradykinin-related cough and the associated runny nose that some ACE-inhibitor users experience.¹⁷

The potassium and kidney-function concerns are broadly similar between the two classes, since both suppress aldosterone through the renin-angiotensin system. The pregnancy contraindication is identical too. The main tolerability advantage of losartan over ACE inhibitors is the absence of cough for most people, and that single difference drives the majority of the switches.

Losartan’s Unusual Benefit for Uric Acid and Gout

This is a side effect running in the other direction, and it is unique to losartan among ARBs. Losartan promotes uric acid excretion through the kidneys through a mechanism that has nothing to do with its angiotensin-blocking action. Other ARBs like irbesartan and valsartan do not share this property.¹⁸ The uric-acid-lowering effect of losartan has been estimated at roughly 20 to 25% in studies of people with high blood pressure, an effect comparable to some dedicated gout medications.¹⁹

Clinical guidelines now recommend losartan as a preferred antihypertensive for patients who also have gout or high uric acid levels.²⁰ If you are taking a different ARB and also struggling with gout flares, it is a conversation worth having with your prescriber, since switching to losartan might address both problems at once. The uric acid benefit is not large enough on its own to replace proper gout treatment in most people, but it is a meaningful bonus that can reduce flare frequency over time.

Pregnancy and Losartan

Losartan carries a black-box warning against use during pregnancy. Like ACE inhibitors, it can cause severe harm to a developing fetus, including reduced amniotic fluid, underdeveloped lungs and skull bones, and fetal death. A case report documented exposure during weeks 20 through 31 of pregnancy that resulted in all of these complications.²¹ The danger is most acute in the second and third trimesters, though the drug is avoided throughout pregnancy as a precaution. Women of reproductive age who take losartan should use reliable contraception and should plan to switch to a pregnancy-safe blood-pressure medication before conceiving or as soon as pregnancy is confirmed.

When to Call Your Doctor About Side Effects

Most people on losartan will never experience anything beyond mild dizziness in the first week or two. But there are a few signals that warrant prompt medical attention:

Facial swelling: Any swelling of the lips, tongue, or throat could indicate angioedema and needs emergency evaluation.
Muscle weakness or irregular heartbeat: These can be signs of dangerously high potassium, especially if you are on a higher dose or have kidney problems.
Persistent diarrhea: Weeks of unexplained loose stools, especially with weight loss or abdominal pain, could point to the rare sprue-like enteropathy described above.
Significant drop in urine output: A sudden decrease can signal acute kidney trouble, particularly in the first few days after starting the drug or after a dose increase.

Routine blood work after starting losartan, typically within a couple of weeks and again at regular intervals, catches most of the potassium and kidney-function shifts before they become symptomatic. If you have been on losartan for years without problems, the risk does not go away entirely, but it does become much less likely that a new issue will emerge out of the blue. The exception is a change in kidney function from aging or a new illness, which can shift the risk profile even after years of uneventful use.